FDA Office of Prescription Drug Promotion (OPDP) · United States
FDA OPDP Boxed Warning Marketing Standards
Promotion of drugs with a boxed warning must convey the boxed-warning risk with prominence comparable to benefit claims, and reminder ads are not permitted for these drugs.
What is FDA OPDP Boxed Warning Marketing Standards?
Promotion of drugs with a boxed warning must convey the boxed-warning risk with prominence comparable to benefit claims, and reminder ads are not permitted for these drugs. Consumer and HCP promotion for prescription drugs whose labeling carries a boxed warning.
general_audience, general_adults_18plus, customers, patients, health_professionals · Prescription Drug · pharma
Where does this rule apply?
United States
Which marketing channels are covered?
all_channels
When does this rule take effect?
2026-11-06
What does this rule require?
Promotion of drugs with a boxed warning must convey the boxed-warning risk with prominence comparable to benefit claims, and reminder ads are not permitted for these drugs.
How can marketing teams comply?
Consumer and HCP promotion for prescription drugs whose labeling carries a boxed warning.
What is FDA OPDP Boxed Warning Marketing Standards?
Promotion of drugs with a boxed warning must convey the boxed-warning risk with prominence comparable to benefit claims, and reminder ads are not permitted for these drugs.
Who does this rule apply to?
general_audience, general_adults_18plus, customers, patients, health_professionals · Prescription Drug · pharma
Drug firms may not promote prescription drugs for unapproved uses; scientific information on unapproved uses may go to HCPs only if separate from promotion and accompanied by the disclosures in FDA's 2025 guidance.
Swiss real estate fund marketing must be identifiable as advertising, refer to the prospectus and KID, present performance fairly with a past-performance caveat, disclose key risks and substantiate sustainability claims.
ASIC expects risk warnings and qualifiers in financial ads to be clear and prominent enough to correct the impression created by headline claims; hidden or unreadable qualifiers can make an ad misleading.
Prop 65 requires clear and reasonable warnings, visible before purchase including online, for California exposures to listed chemicals; safe-harbor warnings must include the signal word, a named chemical, the endpoint and the P65Warnings URL.
Prop 65 requires clear and reasonable warnings before California exposure to listed chemicals; dietary supplements use the food-warning safe harbor, warnings must name a chemical, and online sales must show the warning before purchase.
Canadian fund ads must not describe a fund's risk in a way that conflicts with its Fund Facts or ETF Facts risk rating or imply guarantees that do not exist.
Request a free compliance scan of your homepage and book a time with Warrant.